SURUNKALI UROLOGIK KASALLIKLARGA CHALINGAN BEMORLARNING HAYOT SIFATI
Keywords:
surunkali urologik kasalliklar, hayot sifati, bemor salomatligi, jismoniy holat, ruhiy salomatlik, ijtimoiy moslashuv, urologik kasalliklar, davolash samaradorligi, profilaktika, hayot sifatini baholashAbstract
Ushbu maqolada surunkali urologik kasalliklarga chalingan bemorlarning hayot sifati, kasalliklarning jismoniy, ruhiy va ijtimoiy holatga ta’siri hamda kundalik faoliyatdagi cheklovlar tahlil qilinadi. Surunkali urologik kasalliklar bemorlarning nafaqat jismoniy salomatligiga, balki ruhiy barqarorligi, uyqu sifati, mehnat qobiliyati va ijtimoiy faolligiga ham salbiy ta’sir ko‘rsatishi mumkin. Maqolada hayot sifatini baholashning asosiy mezonlari, kasallik belgilarining bemorlar turmush tarziga ta’siri va davolash samaradorligini oshirishda individual yondashuvning ahamiyati yoritiladi. Shuningdek, bemorlarning hayot sifatini yaxshilashda erta tashxis qo‘yish, samarali davolash, profilaktik tadbirlar va psixologik qo‘llab-quvvatlashning o‘rni ko‘rib chiqiladi. Hayot sifatini kompleks baholash surunkali urologik kasalliklarni davolash natijalarini yaxshilash va bemorlarning kundalik hayotga moslashuvini ta’minlashda muhim ahamiyat kasb etadi.
References
GBD 2021 Chronic Kidney Disease Collaborators. Global, regional, and national burden of chronic kidney disease and its underlying etiologies from 1990 to 2021: a systematic analysis for the Global Burden of Disease Study 2021. [Global epidemiologik tahlil](https://pmc.ncbi.nlm.nih.gov/articles/PMC11831764/?utm_source=chatgpt.com).
Huang J, Chan CK, Yee S, et al. Global burden and temporal trends of lower urinary tract symptoms: a systematic review and meta-analysis. Prostate Cancer and Prostatic Diseases. 2023;26:421–428. [PubMed](https://pubmed.ncbi.nlm.nih.gov/36414786/?utm_source=chatgpt.com).
Muxunov A, Almazan J, Kalinina D, et al. Health-related quality of life in chronic kidney disease patients in low- and lower-middle income countries: a systematic review and meta-analysis. Quality of Life Research. 2026. [PubMed](https://pubmed.ncbi.nlm.nih.gov/41511643/?utm_source=chatgpt.com).
The WHOQOL Group. Development of the World Health Organization WHOQOL-BREF quality of life assessment. Psychological Medicine. 1998;28(3):551–558. doi: [10.1017/S0033291798006667](https://doi.org/10.1017/S0033291798006667?utm_source=chatgpt.com).
Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Medical Care. 1992;30(6):473–483. [PubMed](https://pubmed.ncbi.nlm.nih.gov/1593914/?utm_source=chatgpt.com).
Yangöz ŞT, Turan Kavradim S, Özer Z, Boz İ. Psychometric properties of the Kidney Disease Quality of Life-36 instrument: a systematic review using COSMIN methodology. Nursing & Health Sciences. 2021;23(4):792–806. doi: [10.1111/nhs.12877](https://doi.org/10.1111/nhs.12877?utm_source=chatgpt.com).
The WHOQOL Group. The World Health Organization quality of life assessment (WHOQOL): development and general psychometric properties. Social Science & Medicine. 1998;46(12):1569–1585. doi: [10.1016/S0277-9536(98)00009-4](https://doi.org/10.1016/S0277-9536(98)00009-4?utm_source=chatgpt.com).
Global Burden of Disease Study 2021. Global trends of chronic kidney disease from 1990 to 2021: a systematic analysis for the Global Burden of Disease Study 2021. [PubMed](https://pubmed.ncbi.nlm.nih.gov/40660180/?utm_source=chatgpt.com).





